Matt Kaplan
Director/Board Member at NUVECTIS PHARMA, INC.
Net worth: 365 648 $ as of 2024-05-30
Profile
Mr. Matt L.
Kaplan is a Managing Director & Head of Equity Research at Ladenburg Thalmann & Co., Inc. He has over 14 years of experience as a biotechnology analyst.
His current research focus is therapeutic companies, cardiovascular, and drug delivery.
Prior to joining Ladenburg Thalmann, he was a Partner and the Director of Healthcare Research with Punk, Ziegel & Company.
Previously, he was a Senior Biotechnology Analyst at Evolution Capital and a Director of The Life Sciences Group at The Carson Group.
Before joining The Carson Group and Evolution Capital, Mr. Kaplan had six years of experience as a Research Associate with the Albert Einstein College of Medicine/Montefiore Hospital Department of Cardiology.
Mr. Kaplan received his bachelor’s degree in Biology from the University of Michigan and studied Cellular and Molecular Biology at Columbia University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
NUVECTIS PHARMA, INC.
0.29% | 2024-04-14 | 54,010 ( 0.29% ) | 365 648 $ | 2024-05-30 |
Matt Kaplan active positions
Companies | Position | Start |
---|---|---|
NUVECTIS PHARMA, INC. | Director/Board Member | 2021-08-31 |
Ladenburg Thalmann & Co., Inc. (Broker)
Ladenburg Thalmann & Co., Inc. (Broker) Investment Banks/BrokersFinance Ladenburg Thalmann & Co., Inc. (Broker) is the broker/dealer division of Ladenburg Thalmann & Co., Inc., ultimately held by Advisor Group Holdings, Inc. Headquartered in New York City, the firm was founded in 1876 and offers a full suite of capital markets products and services, including proprietary equity research and a fixed-income trading desk. For institutional asset management clients, the firm provides liquidity, execution, high-quality idea-generating research, and access to corporate management teams. Their institutional coverage includes relationships with over asset management companies all over the world. To corporate clients, they bring access to investor capital, broad distribution capabilities and financial markets advisory. Ladenburg Thalmann is a leader in financing growing middle-market public companies across various industry verticals, including Healthcare & Life Sciences, Yield-Oriented Securities (BDCs, REITs, MLPs), Energy, Power & Infrastructure, and Telecom, Media & Technology. | Director of Research - Equity | 2008-05-01 |
Former positions of Matt Kaplan
Companies | Position | End |
---|---|---|
Punk Ziegel & Co.
Punk Ziegel & Co. Investment Banks/BrokersFinance Located in New York City, Punk, Ziegel & Co. is a specialty investment bank providing a full range of research, equity market making and corporate finance services focusing on high growth sectors within the healthcare technology, biotechnology and life sciences industries. Punk, Ziegel's, in-depth securities analysis begins with the identification of high-growth industries and timely investment ideas before they have been fully exploited by the investment community. Within these industry niches, their analysts pinpoint companies offering leadership potential and maximum investment opportunities. Issue-oriented, in-depth analysis is then generated on a continuing basis to insure that their investment and corporate finance advice remains accurate and up-to-date. | Analyst-Equity | 2008-04-30 |
Carson Group, Inc. (New York)
Carson Group, Inc. (New York) Investment ManagersFinance Carson Group provides financial information services. The firm specializes in global shareholder research and related advisory services. The company was foundedd by David M. Geliebter and is headquartered in New York, NY. | Corporate Officer/Principal | 2003-10-31 |
Albert Einstein College of Medicine, Inc. | Corporate Officer/Principal | - |
Training of Matt Kaplan
University of Michigan | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
NUVECTIS PHARMA, INC. | Health Technology |
Private companies | 3 |
---|---|
Punk Ziegel & Co.
Punk Ziegel & Co. Investment Banks/BrokersFinance Located in New York City, Punk, Ziegel & Co. is a specialty investment bank providing a full range of research, equity market making and corporate finance services focusing on high growth sectors within the healthcare technology, biotechnology and life sciences industries. Punk, Ziegel's, in-depth securities analysis begins with the identification of high-growth industries and timely investment ideas before they have been fully exploited by the investment community. Within these industry niches, their analysts pinpoint companies offering leadership potential and maximum investment opportunities. Issue-oriented, in-depth analysis is then generated on a continuing basis to insure that their investment and corporate finance advice remains accurate and up-to-date. | Finance |
Carson Group, Inc. (New York)
Carson Group, Inc. (New York) Investment ManagersFinance Carson Group provides financial information services. The firm specializes in global shareholder research and related advisory services. The company was foundedd by David M. Geliebter and is headquartered in New York, NY. | Finance |
Ladenburg Thalmann & Co., Inc. (Broker)
Ladenburg Thalmann & Co., Inc. (Broker) Investment Banks/BrokersFinance Ladenburg Thalmann & Co., Inc. (Broker) is the broker/dealer division of Ladenburg Thalmann & Co., Inc., ultimately held by Advisor Group Holdings, Inc. Headquartered in New York City, the firm was founded in 1876 and offers a full suite of capital markets products and services, including proprietary equity research and a fixed-income trading desk. For institutional asset management clients, the firm provides liquidity, execution, high-quality idea-generating research, and access to corporate management teams. Their institutional coverage includes relationships with over asset management companies all over the world. To corporate clients, they bring access to investor capital, broad distribution capabilities and financial markets advisory. Ladenburg Thalmann is a leader in financing growing middle-market public companies across various industry verticals, including Healthcare & Life Sciences, Yield-Oriented Securities (BDCs, REITs, MLPs), Energy, Power & Infrastructure, and Telecom, Media & Technology. | Finance |
- Stock Market
- Insiders
- Matt Kaplan